Skip to Content

H35 (Inqovi cedazuridine 100 mg / decitabine 35 mg)

Generic Name: cedazuridine/decitabine

Pill with imprint H35 is Red, Elliptical / Oval and has been identified as Inqovi cedazuridine 100 mg / decitabine 35 mg. It is supplied by Taiho Oncology, Inc..

Inqovi is used in the treatment of myelodysplastic syndrome and belongs to the drug class antineoplastic combinations. Inqovi cedazuridine 100 mg / decitabine 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for H35

Inqovi cedazuridine 100 mg / decitabine 35 mg H35

Inqovi

Generic Name
cedazuridine/decitabine
Imprint
H35
Strength
cedazuridine 100 mg / decitabine 35 mg
Color
Red
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antineoplastic combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Taiho Oncology, Inc.
Manufacturer
Otsuka Pharmaceutical Co., Ltd.
National Drug Code (NDC)
64842-0727

Get help with Imprint Code FAQs.

Related Images for "H35"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.